[Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)]. 1980

N Kosakai, and T Oguri

We estimated the minimum inhibitory concentrations of following twenty-one antimicrobial agents against 161 strains of Pseudomonas aeruginosa isolated from clinical specimens during 1979. Antimicrobial agents were 5 penicillins (carbenicillin, sulbenicillin, piperacillin, apalcillin and ticarcillin), 3 cephalosporins (cefsulodin, cefoperazone and ceftizoxime), 5 aminoglycosides (gentamicin, tobramycin, dibekacin, amikacin and kanamycin), 3 tetracycclines (tetracyline, doxycycline and minocycline), chloramphenicol, colistin, polymyxin B, nalidixic acid and pipemidic acid. Among penicillins piperacillin and apalcillin showed strongest antibacterial activity and the activity of carbenicillin was weakest. Highly resistant strains against carbenicillin increased rapidly until 1975. Among cephalosporins cefsulodin showed strongest antibacterial activity and its activity was stronger than piperacillin. Antibacterial activity of cefoperazone and ceftizoxime were weaker than cefsulodin, but stronger than carbenicillin and sulbenicillin. Among aminoglycosides kanamycin showed very weak antibacterial activity, but another four drugs showed very strong activity. But resistant strains against these four drugs increased gradually and over 20% of strains was resistant to gentamicin. Among gentamicin, tobramycin and dibekacin cross-resistance was observed, but not between amikacin and these three drugs. Recently the number of strains resistant to both amikacin and gentamicin increased. Tetracyclines, chloramphenicol and nalidixic acid showed rather weak activity, but colistin and polymyxin B showed very strong activity and resistant strains against these drugs were very few. Pipemidic acid showed rather stronger activity than nalidixic acid, but its activity was weaker than aminoglycosides excluding kanamycin.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002228 Carbenicillin Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. Carboxybenzyl Penicillin,Anabactyl,Carbapen,Carbecin,Carbenicillin Disodium,Geopen,Microcillin,Pyopen,Disodium, Carbenicillin,Penicillin, Carboxybenzyl
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin

Related Publications

N Kosakai, and T Oguri
November 1993, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
N Kosakai, and T Oguri
September 1969, Die Medizinische Welt,
N Kosakai, and T Oguri
February 1997, The Japanese journal of antibiotics,
N Kosakai, and T Oguri
December 1977, Mayo Clinic proceedings,
N Kosakai, and T Oguri
October 1970, Applied microbiology,
Copied contents to your clipboard!